ArticlePloS one2024
A Genetic algorithm aided hyper parameter optimization based ensemble model for respiratory disease prediction with Explainable AI.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prediction of the respiratory disease incidence based on environmental factors using machine learning techniques in Penang, Malaysia.Scientific reports · 2026Article
- Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations.Molecular biotechnology · 2026Review
- Clinical outcome prediction in pediatric respiratory infections using hybrid feature selection and a genetic algorithm-optimized machine learning.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the current era, a lot of research is being done in the domain of disease diagnosis using machine learning. In recent times, one of the deadliest respiratory diseases, COVID-19, which causes serious damage to the lungs has claimed a lot of lives globally. Machine learning-based systems can assist clinicians in the early diagnosis of the disease, which can reduce the deadly effects of the disease. For the successful deployment of these machine learning-based systems, hyperparameter-based optimization and feature selection are important issues. Motivated by the above, in this proposal, we design an improved model to predict the existence of respiratory disease among patients by incorporating hyperparameter optimization and feature selection. To optimize the parameters of the machine learning algorithms, hyperparameter optimization with a genetic algorithm is proposed and to reduce the size of the feature set, feature selection is performed using binary grey wolf optimization algorithm. Moreover, to enhance the efficacy of the predictions made by hyperparameter-optimized machine learning models, an ensemble model is proposed using a stacking classifier. Also, explainable AI was incorporated to define the feature importance by making use of Shapely adaptive explanations (SHAP) values. For the experimentation, the publicly accessible Mexico clinical dataset of COVID-19 was used. The results obtained show that the proposed model has superior prediction accuracy in comparison to its counterparts. Moreover, among all the hyperparameter-optimized algorithms, adaboost algorithm outperformed all the other hyperparameter-optimized algorithms. The various performance assessment metrics, including accuracy, precision, recall, AUC, and F1-score, were used to assess the results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.